Catheter Precision (VTAK) Operating Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -132.26% |
| Dec 31, 2025 | -226.42% |
| Sep 30, 2025 | 35.53% |
| Jun 30, 2025 | -31.08% |
| Mar 31, 2025 | -17.17% |
| Dec 31, 2024 | -6.72% |
| Sep 30, 2024 | -5.23% |
| Jun 30, 2024 | -3.86% |
| Mar 31, 2024 | -0.73% |
| Dec 31, 2023 | 4.87% |
| Sep 30, 2023 | 56.72% |
| Jun 30, 2023 | 90.51% |
| Mar 31, 2023 | -709.30% |
| Dec 31, 2022 | -71.75% |
| Sep 30, 2022 | 43.46% |
| Jun 30, 2022 | -53.73% |
| Mar 31, 2022 | 33.41% |
| Dec 31, 2021 | -11.77% |
| Sep 30, 2021 | -2.10% |
| Jun 30, 2021 | -5.41% |
| Mar 31, 2021 | 32.82% |
| Dec 31, 2020 | -36.22% |
| Sep 30, 2020 | 25.79% |
| Jun 30, 2020 | -29.86% |
| Mar 31, 2020 | 20.83% |
| Dec 31, 2019 | 44.05% |
| Sep 30, 2019 | -14.59% |
| Jun 30, 2019 | -2.63% |
| Mar 31, 2019 | 2.07% |
| Dec 31, 2018 | -217.73% |
| Sep 30, 2018 | 42.72% |
| Jun 30, 2018 | -211.70% |
| Mar 31, 2018 | 13.02% |
| Dec 31, 2017 | -80.05% |